The combination of venetoclax and ixazomib selectively and efficiently kills HIV-infected cell lines but has unacceptable toxicity in primary cell models

Alecia Alto, Sekar Natesampillai, Aswath P. Chandrasekar, Ashton Krogman, Anisha Misra, F. N.U. Shweta, Caitlin VanLith, Joseph D. Yao, Nathan W. Cummins, Andrew D. Badley

Research output: Contribution to journal › Article › peer-review

Fingerprint

Dive into the research topics of 'The combination of venetoclax and ixazomib selectively and efficiently kills HIV-infected cell lines but has unacceptable toxicity in primary cell models'. Together they form a unique fingerprint.

Medicine & Life Sciences

Agriculture & Biology